finesse
发表于 2025-3-21 18:09:24
书目名称Biological Mechanisms of Minimal Residual Disease and Systemic Cancer影响因子(影响力)<br> http://impactfactor.cn/if/?ISSN=BK0187399<br><br> <br><br>书目名称Biological Mechanisms of Minimal Residual Disease and Systemic Cancer影响因子(影响力)学科排名<br> http://impactfactor.cn/ifr/?ISSN=BK0187399<br><br> <br><br>书目名称Biological Mechanisms of Minimal Residual Disease and Systemic Cancer网络公开度<br> http://impactfactor.cn/at/?ISSN=BK0187399<br><br> <br><br>书目名称Biological Mechanisms of Minimal Residual Disease and Systemic Cancer网络公开度学科排名<br> http://impactfactor.cn/atr/?ISSN=BK0187399<br><br> <br><br>书目名称Biological Mechanisms of Minimal Residual Disease and Systemic Cancer被引频次<br> http://impactfactor.cn/tc/?ISSN=BK0187399<br><br> <br><br>书目名称Biological Mechanisms of Minimal Residual Disease and Systemic Cancer被引频次学科排名<br> http://impactfactor.cn/tcr/?ISSN=BK0187399<br><br> <br><br>书目名称Biological Mechanisms of Minimal Residual Disease and Systemic Cancer年度引用<br> http://impactfactor.cn/ii/?ISSN=BK0187399<br><br> <br><br>书目名称Biological Mechanisms of Minimal Residual Disease and Systemic Cancer年度引用学科排名<br> http://impactfactor.cn/iir/?ISSN=BK0187399<br><br> <br><br>书目名称Biological Mechanisms of Minimal Residual Disease and Systemic Cancer读者反馈<br> http://impactfactor.cn/5y/?ISSN=BK0187399<br><br> <br><br>书目名称Biological Mechanisms of Minimal Residual Disease and Systemic Cancer读者反馈学科排名<br> http://impactfactor.cn/5yr/?ISSN=BK0187399<br><br> <br><br>
malapropism
发表于 2025-3-21 20:43:14
Minimal Residual Disease in Prostate Cancer,ence, but has not yet been routinely used in clinical care. Investigators have detected MRD by identification of prostate cancer cells in the bone marrow; termed disseminated tumor cells (DTCs) and blood; termed circulating tumor cells (CTCs). Various techniques including PSA-RT PCR, PSA immunocytoc
Decline
发表于 2025-3-22 03:41:50
http://reply.papertrans.cn/19/1874/187399/187399_3.png
赔偿
发表于 2025-3-22 05:14:21
Detection of Minimal Residual Disease and Its Clinical Applications in Melanoma and Breast Cancer Ponitoring for minimal residual disease (MRD) during a disease-free follow-up period would greatly improve patient outcomes through earlier detection of relapse or treatment resistance. However, MRD monitoring in solid tumors such as melanoma and BC are not well established. Here, we discuss the clin
Cytokines
发表于 2025-3-22 11:00:40
http://reply.papertrans.cn/19/1874/187399/187399_5.png
AVOW
发表于 2025-3-22 13:28:20
http://reply.papertrans.cn/19/1874/187399/187399_6.png
Heresy
发表于 2025-3-22 17:39:41
http://reply.papertrans.cn/19/1874/187399/187399_7.png
Tinea-Capitis
发表于 2025-3-22 23:28:47
Minimal Residual Disease in Multiple Myeloma: Impact on Response Assessment, Prognosis and Tumor Hel response exceed 90% and complete response (CR) more than 50% in some studies. Unfortunately, despite higher rates of CR, relapse rates remain high suggesting that persistent disease may not be measured by current techniques. Traditionally, response rates were defined by urine and serum protein ele
heart-murmur
发表于 2025-3-23 03:45:04
http://reply.papertrans.cn/19/1874/187399/187399_9.png
分开
发表于 2025-3-23 08:53:28
http://reply.papertrans.cn/19/1874/187399/187399_10.png